Company intelligence / Profile preview

Neuro.VC

Wilmington, Delaware, United States

Ownership: Private
Development stage: Other

Overview

Neuro.VC is a specialized venture capital firm dedicated to investing in early-stage neuroscience and neurotechnology companies. The firm focuses on transformative solutions for brain-related conditions, including neurological disorders, psychiatric illnesses, and neurodegenerative diseases. By providing both capital and strategic expertise, Neuro.VC aims to accelerate the development of breakthrough therapies and diagnostic tools in the central nervous system space. Their portfolio typically includes companies working on novel drug discovery, digital therapeutics, and advanced neuro-monitoring devices.

Therapeutic areas: PsychiatryNeurology
Industry: Investors

Beyond the preview

Go deeper on Neuro.VC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro.VC.

Explore the full profile